Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2022 Mar;52(2):101-103.
doi: 10.1016/j.idnow.2022.01.002. Epub 2022 Jan 20.

COVID-19 reinfection after pregnancy

L Gobin  1 , A Vallée  2 , D Zucman  3 , M Carbonnel  4 , J Laperrelle  5 , O Brugière  6 , A Martin  7 , J-M Ayoubi  8 , E Farfour  9
Affiliations
Case Reports

COVID-19 reinfection after pregnancy

L Gobin et al. Infect Dis Now. 2022 Mar.

Abstract

Background: There have been reports of COVID-19 reinfections, but the immunological characterization of these cases is partial. We report a case of reinfection with SARS-CoV-2, where the first infection occurred in the course of late pregnancy.

Case presentation: On May 27, 2020, a 37-year-old woman gave birth at full term, 3 hours after full dilatation. She developed fever (38.3°C) after delivery. Mild biological anomalies compatible with COVID-19 were observed: lymphopenia, thrombocytopenia, elevated D-Dimers, CRP, and LDH. At 6-month follow-up, she reported having contracted COVID-19 with high fever, rhinorrhea, hand frostbites, cough, headache, dysgeusia and anosmia.

Conclusions: We report a case of COVID-19 reinfection with a first mild infection during late pregnancy and a more aggressive second infection 5 months later.

Keywords: COVID-19; Pregnancy; Reinfection.

PubMed Disclaimer

References

    1. Edridge A.W.D., Kaczorowska J., Hoste A.C.R., Bakker M., Klein M., Loens K., et al. Seasonal coronavirus protective immunity is short-lasting. Nat Med. 2020;26:1691–1693. doi: 10.1038/s41591-020-1083-1. - DOI - PubMed
    1. Chen D., Xu W., Lei Z., Huang Z., Liu J., Gao Z., et al. Recurrence of positive SARS-CoV-2 RNA in COVID-19: a case report. Int J Infect Dis. 2020;93:297–299. doi: 10.1016/j.ijid.2020.03.003. - DOI - PMC - PubMed
    1. Roumier M., Paule R., Vallée A., Rohmer J., Ballester M., Brun A.-L., et al. Tocilizumab for severe worsening COVID-19 pneumonia: a propensity score analysis. J Clin Immunol. 2020 doi: 10.1007/s10875-020-00911-6. - DOI - PMC - PubMed
    1. Stebbing J., Phelan A., Griffin I., Tucker C., Oechsle O., Smith D., et al. COVID-19: combining antiviral and anti-inflammatory treatments. Lancet Infect Dis. 2020;20:400–402. doi: 10.1016/S1473-3099(20)30132-8. - DOI - PMC - PubMed
    1. Loustau M., Wiendl H., Ferrone S., Carosella E.D. HLA-G 2012 conference: the 15-year milestone update. Tissue Antigens. 2013;81:127–136. doi: 10.1111/tan.12053. - DOI - PubMed

Publication types